Breaking News: Daiichi Sankyo and Merck Join Forces for Global Development and Commercialization of Three Revolutionary Daiichi Sankyo DXD ADCs
Breaking News: Daiichi Sankyo and Merck Join Forces for Global Development and Commercialization of Three Revolutionary Daiichi Sankyo DXD ADCs Description: Collaboration combines Daiichi Sankyo’s proven ADC expertise and DXd technology with Merck’s deep experience in oncology and clinical development capabilities to advance and expand the reach of ADCs for patients across multiple types of…